Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years
Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
D. N. Andreev [verfasserIn] I. V. Maev [verfasserIn] Yu. A. Kucheryavyy [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Терапевтический архив - "Consilium Medicum" Publishing house, 2018, 92(2020), 11, Seite 24-30 |
|---|---|
| Übergeordnetes Werk: |
volume:92 ; year:2020 ; number:11 ; pages:24-30 |
| Links: |
|---|
| Katalog-ID: |
DOAJ078262968 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ078262968 | ||
| 003 | DE-627 | ||
| 005 | 20230309155653.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2020 xx |||||o 00| ||rus c | ||
| 035 | |a (DE-627)DOAJ078262968 | ||
| 035 | |a (DE-599)DOAJ4ab665e443854839990db99d672a0970 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a D. N. Andreev |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. | ||
| 650 | 4 | |a helicobacter pylori | |
| 650 | 4 | |a eradication therapy | |
| 650 | 4 | |a resistance | |
| 650 | 4 | |a sensitivity | |
| 650 | 4 | |a antibacterial drugs | |
| 650 | 4 | |a clarithromycin | |
| 650 | 4 | |a metronidazole | |
| 650 | 4 | |a amoxicillin | |
| 650 | 4 | |a levofloxacin | |
| 650 | 4 | |a tetracycline | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a I. V. Maev |e verfasserin |4 aut | |
| 700 | 0 | |a Yu. A. Kucheryavyy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Терапевтический архив |d "Consilium Medicum" Publishing house, 2018 |g 92(2020), 11, Seite 24-30 |w (DE-627)1760620270 |x 23095342 |7 nnns |
| 773 | 1 | 8 | |g volume:92 |g year:2020 |g number:11 |g pages:24-30 |
| 856 | 4 | 0 | |u https://doaj.org/article/4ab665e443854839990db99d672a0970 |z kostenfrei |
| 856 | 4 | 0 | |u https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0040-3660 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2309-5342 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 92 |j 2020 |e 11 |h 24-30 | ||
| author_variant |
d n a dna i v m ivm y a k yak |
|---|---|
| matchkey_str |
article:23095342:2020----::eioatryoieitnenhrsineeainmtaayios |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R I. V. Maev verfasserin aut Yu. A. Kucheryavyy verfasserin aut In Терапевтический архив "Consilium Medicum" Publishing house, 2018 92(2020), 11, Seite 24-30 (DE-627)1760620270 23095342 nnns volume:92 year:2020 number:11 pages:24-30 https://doaj.org/article/4ab665e443854839990db99d672a0970 kostenfrei https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 kostenfrei https://doaj.org/toc/0040-3660 Journal toc kostenfrei https://doaj.org/toc/2309-5342 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 92 2020 11 24-30 |
| spelling |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R I. V. Maev verfasserin aut Yu. A. Kucheryavyy verfasserin aut In Терапевтический архив "Consilium Medicum" Publishing house, 2018 92(2020), 11, Seite 24-30 (DE-627)1760620270 23095342 nnns volume:92 year:2020 number:11 pages:24-30 https://doaj.org/article/4ab665e443854839990db99d672a0970 kostenfrei https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 kostenfrei https://doaj.org/toc/0040-3660 Journal toc kostenfrei https://doaj.org/toc/2309-5342 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 92 2020 11 24-30 |
| allfields_unstemmed |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R I. V. Maev verfasserin aut Yu. A. Kucheryavyy verfasserin aut In Терапевтический архив "Consilium Medicum" Publishing house, 2018 92(2020), 11, Seite 24-30 (DE-627)1760620270 23095342 nnns volume:92 year:2020 number:11 pages:24-30 https://doaj.org/article/4ab665e443854839990db99d672a0970 kostenfrei https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 kostenfrei https://doaj.org/toc/0040-3660 Journal toc kostenfrei https://doaj.org/toc/2309-5342 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 92 2020 11 24-30 |
| allfieldsGer |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R I. V. Maev verfasserin aut Yu. A. Kucheryavyy verfasserin aut In Терапевтический архив "Consilium Medicum" Publishing house, 2018 92(2020), 11, Seite 24-30 (DE-627)1760620270 23095342 nnns volume:92 year:2020 number:11 pages:24-30 https://doaj.org/article/4ab665e443854839990db99d672a0970 kostenfrei https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 kostenfrei https://doaj.org/toc/0040-3660 Journal toc kostenfrei https://doaj.org/toc/2309-5342 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 92 2020 11 24-30 |
| allfieldsSound |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R I. V. Maev verfasserin aut Yu. A. Kucheryavyy verfasserin aut In Терапевтический архив "Consilium Medicum" Publishing house, 2018 92(2020), 11, Seite 24-30 (DE-627)1760620270 23095342 nnns volume:92 year:2020 number:11 pages:24-30 https://doaj.org/article/4ab665e443854839990db99d672a0970 kostenfrei https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 kostenfrei https://doaj.org/toc/0040-3660 Journal toc kostenfrei https://doaj.org/toc/2309-5342 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 92 2020 11 24-30 |
| language |
Russian |
| source |
In Терапевтический архив 92(2020), 11, Seite 24-30 volume:92 year:2020 number:11 pages:24-30 |
| sourceStr |
In Терапевтический архив 92(2020), 11, Seite 24-30 volume:92 year:2020 number:11 pages:24-30 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Терапевтический архив |
| authorswithroles_txt_mv |
D. N. Andreev @@aut@@ I. V. Maev @@aut@@ Yu. A. Kucheryavyy @@aut@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
1760620270 |
| id |
DOAJ078262968 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ078262968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309155653.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx |||||o 00| ||rus c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ078262968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4ab665e443854839990db99d672a0970</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">helicobacter pylori</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eradication therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sensitivity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibacterial drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clarithromycin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metronidazole</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">amoxicillin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">levofloxacin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tetracycline</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Maev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. A. Kucheryavyy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Терапевтический архив</subfield><subfield code="d">"Consilium Medicum" Publishing house, 2018</subfield><subfield code="g">92(2020), 11, Seite 24-30</subfield><subfield code="w">(DE-627)1760620270</subfield><subfield code="x">23095342</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:92</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:24-30</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4ab665e443854839990db99d672a0970</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0040-3660</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2309-5342</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">92</subfield><subfield code="j">2020</subfield><subfield code="e">11</subfield><subfield code="h">24-30</subfield></datafield></record></collection>
|
| author |
D. N. Andreev |
| spellingShingle |
D. N. Andreev misc helicobacter pylori misc eradication therapy misc resistance misc sensitivity misc antibacterial drugs misc clarithromycin misc metronidazole misc amoxicillin misc levofloxacin misc tetracycline misc Medicine misc R Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| authorStr |
D. N. Andreev |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760620270 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
23095342 |
| topic_title |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years helicobacter pylori eradication therapy resistance sensitivity antibacterial drugs clarithromycin metronidazole amoxicillin levofloxacin tetracycline |
| topic |
misc helicobacter pylori misc eradication therapy misc resistance misc sensitivity misc antibacterial drugs misc clarithromycin misc metronidazole misc amoxicillin misc levofloxacin misc tetracycline misc Medicine misc R |
| topic_unstemmed |
misc helicobacter pylori misc eradication therapy misc resistance misc sensitivity misc antibacterial drugs misc clarithromycin misc metronidazole misc amoxicillin misc levofloxacin misc tetracycline misc Medicine misc R |
| topic_browse |
misc helicobacter pylori misc eradication therapy misc resistance misc sensitivity misc antibacterial drugs misc clarithromycin misc metronidazole misc amoxicillin misc levofloxacin misc tetracycline misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Терапевтический архив |
| hierarchy_parent_id |
1760620270 |
| hierarchy_top_title |
Терапевтический архив |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760620270 |
| title |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| ctrlnum |
(DE-627)DOAJ078262968 (DE-599)DOAJ4ab665e443854839990db99d672a0970 |
| title_full |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| author_sort |
D. N. Andreev |
| journal |
Терапевтический архив |
| journalStr |
Терапевтический архив |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
txt |
| container_start_page |
24 |
| author_browse |
D. N. Andreev I. V. Maev Yu. A. Kucheryavyy |
| container_volume |
92 |
| format_se |
Elektronische Aufsätze |
| author-letter |
D. N. Andreev |
| author2-role |
verfasserin |
| title_sort |
helicobacter pylori resistance in the russian federation: a meta-analysis of studies over the past 10 years |
| title_auth |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| abstract |
Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. |
| abstractGer |
Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. |
| abstract_unstemmed |
Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
11 |
| title_short |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
| url |
https://doaj.org/article/4ab665e443854839990db99d672a0970 https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106 https://doaj.org/toc/0040-3660 https://doaj.org/toc/2309-5342 |
| remote_bool |
true |
| author2 |
I. V. Maev Yu. A. Kucheryavyy |
| author2Str |
I. V. Maev Yu. A. Kucheryavyy |
| ppnlink |
1760620270 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| up_date |
2024-07-03T16:55:01.007Z |
| _version_ |
1803577669459116032 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ078262968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309155653.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx |||||o 00| ||rus c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ078262968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4ab665e443854839990db99d672a0970</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Aim. Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. Methods. A search for studies were carried out in electronic databases MEDLINE/PubMed, EMBASE, Cochrane, Russian Science Citation Index. We analyzed the papers published over the past 10 years (2011 to 2020). In the final analysis, publications were selected from periodical peer-reviewed foreign and Russian publications, in which validated tests for assessing the microorganism resistance were used with detailed descriptive statistics, which allows the obtained data to be included in the meta-analysis. Results. The final analysis included 11 studies (808 isolates). H. pylori resistance to clarithromycin was 10.39% (95% confidence interval CI 7.10314.219), metronidazole 33.95% (95% CI 15.32955.639), amoxicillin 1.35% (95% CI 0.281 3.202), levofloxacin 20.0% (95% CI 12.63728.574), tetracycline 0.98% (95% CI 0.3532.163). Double clarithromycin-metronidazole resistance was reported in 2.7% (95% CI 1.1364.345). Conclusion. This meta-analysis is the first analytical work that allows objectifying the current structure of H. pylori antibiotic resistance in the Russian Federation. The data obtained in the analysis of publications over the past 10 years indicate a low resistance of the microorganism to clarithromycin (less than the regulated threshold of 15%), which allows us to consider the triple regimen of eradication therapy as a first-line therapy in our country.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">helicobacter pylori</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">eradication therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sensitivity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibacterial drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clarithromycin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metronidazole</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">amoxicillin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">levofloxacin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tetracycline</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Maev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. A. Kucheryavyy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Терапевтический архив</subfield><subfield code="d">"Consilium Medicum" Publishing house, 2018</subfield><subfield code="g">92(2020), 11, Seite 24-30</subfield><subfield code="w">(DE-627)1760620270</subfield><subfield code="x">23095342</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:92</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:24-30</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4ab665e443854839990db99d672a0970</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ter-arkhiv.ru/0040-3660/article/viewFile/56917/40106</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0040-3660</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2309-5342</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">92</subfield><subfield code="j">2020</subfield><subfield code="e">11</subfield><subfield code="h">24-30</subfield></datafield></record></collection>
|
| score |
7.4022894 |